Modulating CD226 and PD-(L)1 pathways improves CMV-specific CD8+T cell responses in the absence of IL-2 (Vol 58, pg 307, 2025)

Abstract

BMB Reports recently published the article “Modulating CD226 and PD-(L)1 pathways improves CMV-specific CD8+T cell responses in the absence of IL-2” (BMB Rep. 2025; Vol. 58, No.7, pp.307-312) by Hye-In Sim et al. The original publication inadvertently omitted the ACKNOWLEDGEMENTS section. This section has now been added to the online version.

ACKNOWLEDGEMENTS

This work was supported by an intramural grant from KIST and Asan Medical Center (2022IP0092-1) and by grants from the National Research Foundation of Korea (NRF) (RS-2024-00338729 to H. Jin and RS-2024-00337093 to Y. Park).

The authors and editorial office apologize for any inconvenience or confusion this omission may have caused to the authors and readers.